The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis
Open accessAbstract
The functional contribution of myofibroblasts in fibrosis is not well understood. Using a new genetic mouse model to track and isolate myofibroblasts, we performed gene expression profiling followed by biological validation to identify HE4 (encoding human epididymis protein 4, also known as WAP 4-disulfide core domain-2 or Wfdc2) as the most upregulated gene in fibrosis-associated myofibroblasts. The HE4 gene encodes for a putative serine protease inhibitor that is upregulated in human and mouse fibrotic kidneys and is elevated in the serum of patients with kidney fibrosis. HE4 suppresses the activity of multiple proteases, including serine proteases and matrix metalloproteinases, and specifically inhibits their capacity to degrade type I collagen. In particular, we identified two serine proteases, Prss35 and Prss23, as HE4 targets with functional relevance in kidney fibrosis. Administration of HE4-neutralizing antibodies accelerated collagen I degradation and inhibited fibrosis in three different mouse models of renal disease. Collectively these studies suggest that HE4 is a potential biomarker of renal fibrosis and a new therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Tubulointerstitial Fibrosis
Zeisberg, M., & Neilson, E. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080793 · Cited by 868
Methylation determines fibroblast activation and fibrogenesis in the kidney
Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M. (2010) · Nature Medicine · doi:10.1038/nm.2135 · Cited by 639
Self-citationMolecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Drapkin, R., von Horsten, H. H., Lin, Y., Mok, S. C., Crum, C. P., Welch, W. R., & Hecht, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3924 · Cited by 570
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Galgano, M. T., Hampton, G. M., & Frierson, H. F. (2006) · Modern Pathology · doi:10.1038/modpathol.3800612 · Cited by 437
Kirchhoff, C., Habben, I., Ivell, R., & Krull, N. (1991) · Biology of Reproduction · doi:10.1095/biolreprod45.2.350 · Cited by 395
Role of matrix metalloproteinases in renal pathophysiologies
Catania, J. M., Chen, G., & Parrish, A. R. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00421.2006 · Cited by 372
Fibroblasts and myofibroblasts in renal fibrosis
Meran, S., & Steadman, R. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00764.x · Cited by 346
Bielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Zeisberg, M., Bottiglio, C., Kumar, N., Maeshima, Y., Strutz, F., Müller, G. A., & Kalluri, R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00191.2002 · Cited by 309
Self-citationPAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
Oda, T., Jung, Y. O., Kim, H. S., Cai, X., López-Guisa, J. M., Ikeda, Y., & Eddy, A. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.030002587.x · Cited by 274
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Sugimoto, H., LeBleu, V. S., Bosukonda, D., Keck, P., Taduri, G., Bechtel, W., Okada, H., Carlson, W., Bey, P., Rusckowski, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2629 · Cited by 231
Self-citationCLAUSS, A., LILJA, H., & LUNDWALL, Å. (2002) · Biochemical Journal · doi:10.1042/bj20020869 · Cited by 213
Bingle, L., Cross, S. S., High, A. S., Wallace, W. A., Rassl, D. M., Yuan, G., Hellström, I., Campos, M., & Bingle, C. D. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-61 · Cited by 201
The origin of interstitial myofibroblasts in chronic kidney disease
Grgic, I., Duffield, J. S., & Humphreys, B. D. (2012) · Pediatric Nephrology · doi:10.1007/s00467-011-1772-6 · Cited by 197
αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse
Hahm, K., Lukashev, M. E., Luo, Y., Yang, W. J., Dolinski, B. M., Weinreb, P. H., Simon, K. J., Chun Wang, L., Leone, D. R., Lobb, R. R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060158 · Cited by 190
Self-citationRole of fibroblast activation in inducing interstitial fibrosis.
Zeisberg, M., Strutz, F. M., & Muller, G. A. (2000) · PubMed · Cited by 135
Matsuo, S., Lepez-Guisa, J. M., Cai, X., Okamura, D. M., Alpers, C. E., Bumgarner, R. E., Peters, M. A., Zhang, G., & Eddy, A. A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00327.x · Cited by 128
Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy
Zhang, G., Kim, H., Cai, X., López-Guisa, J. M., Alpers, C. E., Liu, Y., Carmeliet, P., & Eddy, A. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000064292.37793.fb · Cited by 109
The evolution of a genetic locus encoding small serine proteinase inhibitors
Clauss, A., Lilja, H. G., & Lundwall, Å. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.125 · Cited by 93
Renal Interstitial Fibrosis: A Critical Evaluation of the Origin of Myofibroblasts
Barnes, J. L., & Glass, W. F. (2011) · Contributions to nephrology · doi:10.1159/000313946 · Cited by 90
Renal fibrosis and the origin of the renal fibroblast
Strutz, F. M., & Muller, G. A. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl199 · Cited by 85
Molecular Correlates of Renal Function in Kidney Transplant Biopsies
Bunnag, S., Einecke, G., REEVE, J. P., Jhangri, G. S., Mueller, T., Sis, B., Hidalgo, L. G., Mengel, M., Kayser, D., Kaplan, B. E., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080863 · Cited by 69
Stem Cell Therapies Benefit Alport Syndrome
LeBleu, V. S., Sugimoto, H., Mundel, T. M., Gerami‐Naini, B., Finan, E., Miller, C. A., Gattone, V. H., Lu, L., Shield, C. F., Folkman, J., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010123 · Cited by 68
Self-citationPossible Mechanisms of Renal Fibrosis
Okada, H., Strutz, F. M., Danoff, T. M., Kalluri, R., & Neilson, E. G. (2015) · Contributions to nephrology · doi:10.1159/000425088 · Cited by 48
Self-citationSivashanmugam, P., Hall, S. H., Hamil, K. G., French, F. S., O’Rand, M. G., & Richardson, R. T. (2003) · Gene · doi:10.1016/s0378-1119(03)00608-5 · Cited by 47
LeBleu, V. S., Sugimoto, H., Miller, C. A., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.3700715 · Cited by 46
Self-citation
Cited by
Clinical and therapeutic relevance of cancer-associated fibroblasts
Chen, Y., McAndrews, K. M., & Kalluri, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00546-5 · Cited by 1,230
Self-citationExosomes in the tumor microenvironment as mediators of cancer therapy resistance
Li, I., & Nabet, B. Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0975-5 · Cited by 416
(2022) · doi:10.1158/2159-8290.cd-20-1484 · Cited by 311
Subramanian, A., Sidhom, E.-H., Emani, M., Vernon, K., Sahakian, N., Zhou, Y., Kost-Alimova, M., Slyper, M., Waldman, J., Dionne, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13382-0 · Cited by 211
Schuermans, A., Pournamdari, A. B., Lee, J., Bhukar, R., Ganesh, S., Darosa, N., Small, A. M., Yu, Z., Hornsby, W., Koyama, S., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00567-0 · Cited by 71
Metadata
- Authors
- LeBleu, V. S., Teng, Y., O'Connell, J. T., Charytan, D., Müller, G. A., Müller, C. A., Sugimoto, H., & Kalluri, R.
- Venue
- Nature Medicine
- Published
- 2013-01-27
- Volume
- 19
- Issue
- 2
- Pages
- 227-231
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1995011038
- Cited by
- 260
- References
- 27
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.